Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Greater focus on designing automated intraosseous infusion devices is expected to offer lucrative growth opportunities for players in the global ...
InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...
Boston, April 08, 2026 (GLOBE NEWSWIRE)-- The global market for infusion pumps and devices is projected to grow from $9 billion in 2024 to $14.2 billion by 2030, reflecting a compound annual growth ...
A Prescription Drug User Fee Act target date of February 1, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) ...
The healthcare landscape is witnessing a remarkable surge in the global intraosseous infusion devices industry demand is poised to escalate from its current value of US$ 4.4 billion in 2023 to an ...
DUBLIN--(BUSINESS WIRE)--The "Global Infusion Therapy Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The infusion therapy devices market will register a CAGR of ...
DUBLIN--(BUSINESS WIRE)--The "Infusion Pumps and Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Infusion pumps are widely used in hospitals, ...
US & Canada, Jan. 24, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, “Infusion Devices Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend ...
Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results